Open AccessSafety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial
Author(s) -
Leef George C.,
Hellkamp Anne S.,
Patel Manesh R.,
Becker Richard C.,
Berkowitz Scott D.,
Breithardt Günter,
Halperin Jonathan L.,
Hankey Graeme J.,
Hacke Werner,
Nessel Christopher C.,
Singer Daniel E.,
Fox Keith A.A.,
Mahaffey Kenneth W.,
Piccini Jonathan P.
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004663
Subject(s) - rivaroxaban , medicine , atrial fibrillation , warfarin , stroke (engine) , myocardial infarction , randomized controlled trial , embolism , hazard ratio , surgery , cardiology , anesthesia , confidence interval , mechanical engineering , engineering
Although implantation of cardiac implantable electronic devices (CIEDs) in patients receiving warfarin is well studied, limited data are available on the use of oral factor Xa inhibitors in this setting.